RELX Plc (RELX) is listed on NYSE and operates in the Publishing industry (Communication Services sector).
RELX PLC provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals to progress in science and advance healthcare. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as increases the productivity. The Exhibitions segment is involved in the events business that combines face-to-face with data and digital tools to help customers learn about markets, source products, and complete transactions. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. The company was incorporated in 1903 and is headquartered in London, the United Kingdom.
| Rating | Analysts |
|---|---|
| Strong Buy | 0 |
| Buy | 5 |
| Hold | 2 |
| Sell | 0 |
| Strong Sell | 0 |
RELX Plc is a global provider of information-based analytics and decision tools for professional and business clients across North America, Europe, and other regions. The company operates through four main segments: Risk, Scientific, Technical & Medical, Legal, and Exhibitions. The Risk segment delivers analytics and decision tools that integrate public and industry-specific content with technology to aid clients in risk evaluation and prediction. The Scientific, Technical & Medical segment offers information and analytics to support scientific progress and healthcare advancement. The Legal segment provides legal, regulatory, and business information and analytics to enhance decision-making and productivity. The Exhibitions segment focuses on the events business, combining face-to-face interactions with data and digital tools to facilitate market learning, product sourcing, and transaction completion. Originally known as Reed Elsevier PLC, the company rebranded to RELX Plc in July 2015. Established in 1903, RELX Plc is headquartered in London, United Kingdom.
Over the past three fiscal years, the company has demonstrated a solid trajectory of profitability and cash generation. Revenue showed an inconsistent pattern, growing at a modest CAGR of 1.2% from £9.16 billion in 2023 to £9.38 billion in 2025. Despite this, the company achieved consistent improvements in profitability, with operating margins increasing by 1.8pp from 29.3% to 31.1%, and net margins rising by 2.1pp from 19.4% to 21.5%. This margin expansion was supported by a consistent increase in EPS, which grew at an 8.2% CAGR, reaching £1.10 in 2025. Cash flow generation was robust, with operating cash flow increasing at a 7.0% CAGR to £2.81 billion, and free cash flow (FCF) growing significantly at an 18.8% CAGR to £2.79 billion, resulting in an FCF margin expansion of 8.2pp to 29.8%. The company's capital efficiency improved, as evidenced by a consistent increase in ROIC, reaching 23.6% in 2025, and a strong FCF conversion rate of 99.3%. Despite these positive trends, net debt increased consistently, reaching £7.19 billion, and liquidity ratios remained below 1, indicating potential short-term financial constraints. However, the company maintained a healthy interest coverage ratio of 10.2x, suggesting it can comfortably meet its interest obligations. Overall, the company's strategic focus on profitability and cash flow generation has enhanced shareholder value, as reflected in the reduction of share count by 3.1%, which further amplified per-share gains.
Recent developments for RELX have been marked by a significant analyst upgrade and institutional trading activity. On April 8, Citi upgraded RELX to a 'buy' rating, citing that concerns over AI have created a buying opportunity within the de-rated European media sector. This upgrade reflects a positive outlook on RELX's potential amidst market apprehensions. Additionally, institutional trading activity has been notable, with Boston Common Asset Management LLC selling 24,702 shares of RELX, reducing its holdings to a value of $3,071,000 as of the latest SEC filing. Meanwhile, Acadian Asset Management LLC increased its position by purchasing an additional 5,374 shares, now holding 14,302 shares worth $720,000. These transactions suggest active portfolio adjustments among institutional investors. Furthermore, LexisNexis Risk Solutions, a RELX subsidiary, expanded its medical data access for life insurers through its Agenium alliance, enhancing the efficiency of accessing electronic health records. This strategic initiative aims to streamline the insurance application process, reflecting RELX's ongoing efforts to leverage data for operational improvements. Overall, these developments highlight RELX's strategic positioning and investor interest amidst evolving market dynamics.